These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear. Inagaki N, Miura T, Ohira K, Nagai H, Xu QA, Koda A. J Pharmacobiodyn; 1990 May; 13(5):272-7. PubMed ID: 2177106 [Abstract] [Full Text] [Related]
3. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Weg VB, Watson ML, Cordeiro RS, Williams TJ. Eur J Pharmacol; 1991 Nov 05; 204(2):157-63. PubMed ID: 1687219 [Abstract] [Full Text] [Related]
4. Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats. Inagaki N, Miura T, Nagai H, Koda A. Jpn J Pharmacol; 1988 Feb 05; 46(2):189-92. PubMed ID: 3379829 [Abstract] [Full Text] [Related]
6. Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats. Inagaki N, Miura T, Daikoku M, Nagai H, Koda A. Pharmacology; 1989 Feb 05; 39(1):19-27. PubMed ID: 2479953 [Abstract] [Full Text] [Related]
7. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Hwang SB, Li CL, Lam MH, Shen TY. Lab Invest; 1985 Jun 05; 52(6):617-30. PubMed ID: 3925239 [Abstract] [Full Text] [Related]
8. Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis. Woodward DF, Wasserman MA, Weichman BM. Eur J Pharmacol; 1983 Sep 16; 93(1-2):9-19. PubMed ID: 6313400 [Abstract] [Full Text] [Related]
12. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung. Davidson D, Drafta D. J Appl Physiol (1985); 1992 Sep 16; 73(3):955-61. PubMed ID: 1400062 [Abstract] [Full Text] [Related]
13. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J, Rotilio D, Vargaftig BB. Br J Pharmacol; 1984 Jul 16; 82(3):565-75. PubMed ID: 6430375 [Abstract] [Full Text] [Related]
14. Vascular permeability increase in the mouse paw during the passive anaphylaxis reaction. Qu XF, Yamaki K, Oh-ishi S. Jpn J Pharmacol; 1991 Oct 16; 57(2):255-7. PubMed ID: 1812304 [Abstract] [Full Text] [Related]
15. Role of leukotrienes in vascular changes in the rat mesentery and skin in anaphylaxis. Leng W, Kuo CG, Qureshi R, Jakschik BA. J Immunol; 1988 Apr 01; 140(7):2361-8. PubMed ID: 3351303 [Abstract] [Full Text] [Related]
16. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions. Ueno A, Tokumasu T, Naraba H, Oh-ishi S. Jpn J Pharmacol; 1996 Apr 01; 70(4):285-90. PubMed ID: 8774757 [Abstract] [Full Text] [Related]
17. Leukotriene receptors in the skin of rats differ from those of mouse skin or rat stomach strip. Miura T, Inagaki N, Goto S, Yoshida K, Nagai H, Koda A. Eur J Pharmacol; 1992 Oct 20; 221(2-3):333-42. PubMed ID: 1330627 [Abstract] [Full Text] [Related]
18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B. Arzneimittelforschung; 1995 May 20; 45(5):559-68. PubMed ID: 7541995 [Abstract] [Full Text] [Related]
19. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism. Hatakeyama K, Yano S, Watanabe K. Jpn J Pharmacol; 1991 Jul 20; 56(3):271-7. PubMed ID: 1910120 [Abstract] [Full Text] [Related]
20. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions. Koda A, Nagai H, Mori H, Inagaki N, Nishiyori T, Matsuura N, Iwamoto T, Furukawa K, Yamada H, Goto S. Arzneimittelforschung; 1986 Nov 20; 36(11):1609-18. PubMed ID: 2434109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]